000 | 01807 a2200433 4500 | ||
---|---|---|---|
005 | 20250513035651.0 | ||
264 | 0 | _c19951010 | |
008 | 199510s 0 0 eng d | ||
022 | _a0303-7207 | ||
024 | 7 |
_a10.1016/0303-7207(95)03504-z _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKjøller, L | |
245 | 0 | 0 |
_aDifferential regulation of urokinase-type-1 inhibitor complex endocytosis by phorbol esters in different cell lines is associated with differential regulation of alpha 2-macroglobulin receptor and urokinase receptor expression. _h[electronic resource] |
260 |
_bMolecular and cellular endocrinology _cApr 1995 |
||
300 |
_a209-17 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCell Line, Transformed |
650 | 0 | 4 | _aChlorocebus aethiops |
650 | 0 | 4 |
_aCoated Pits, Cell-Membrane _xmetabolism |
650 | 0 | 4 |
_aEndocytosis _xdrug effects |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney _xcytology |
650 | 0 | 4 | _aLow Density Lipoprotein Receptor-Related Protein-1 |
650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xpharmacology |
650 | 0 | 4 |
_aReceptors, Cell Surface _xdrug effects |
650 | 0 | 4 |
_aReceptors, Immunologic _xmetabolism |
650 | 0 | 4 | _aReceptors, Urokinase Plasminogen Activator |
650 | 0 | 4 | _aSwine |
650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xantagonists & inhibitors |
700 | 1 | _aSimonsen, A C | |
700 | 1 | _aEllgaard, L | |
700 | 1 | _aAndreasen, P A | |
773 | 0 |
_tMolecular and cellular endocrinology _gvol. 109 _gno. 2 _gp. 209-17 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0303-7207(95)03504-z _zAvailable from publisher's website |
999 |
_c7664415 _d7664415 |